Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

AIMS/HYPOTHESIS: The long-term effects of successful immune therapies for treatment of type 1 diabetes have not been well studied. The Autoimmunity-Blocking Antibody for Tolerance (AbATE) trial evaluated teplizumab, an Fc receptor non-binding humanised anti-CD3 monoclonal antibody in individuals wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetologia
Main Authors: Perdigoto, Ana Luisa, Preston-Hurlburt, Paula, Clark, Pamela, Long, S. Alice, Linsley, Peter S., Harris, Kristina M., Gitelman, Steven E., Greenbaum, Carla J., Gottlieb, Peter A., Hagopian, William, Woodwyk, Alyssa, Dziura, James, Herold, Kevan C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402971/
https://ncbi.nlm.nih.gov/pubmed/30569273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-018-4786-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados